Their Patient Care Trust has the same vulnerabilities as pensions and personal retirement accounts. They have to take enough risk to beat inflation. In the long-term, that is … risky.
They only have to beat inflation in cryopreservation costs, though, which, like other technologies, is likely to get cheaper over time. The only exception to that, I think, would be property taxes on the facility (which will increase with general inflation), and perhaps wages for any unavoidable human labor.
But the question isn’t really whether it’s got cheaper, the question is whether it’s risen sufficiently slowly relative to inflation that sufficiently low-risk investments can safely (enough) cover it over the long term. Getting much cheaper is sufficient for that, of course, but not necessary. Any idea how it looks from that perspective?
Their Patient Care Trust has the same vulnerabilities as pensions and personal retirement accounts. They have to take enough risk to beat inflation. In the long-term, that is … risky.
They only have to beat inflation in cryopreservation costs, though, which, like other technologies, is likely to get cheaper over time. The only exception to that, I think, would be property taxes on the facility (which will increase with general inflation), and perhaps wages for any unavoidable human labor.
The technology hasn’t got much cheaper in the last few decades, partly because of its small scale.
But the question isn’t really whether it’s got cheaper, the question is whether it’s risen sufficiently slowly relative to inflation that sufficiently low-risk investments can safely (enough) cover it over the long term. Getting much cheaper is sufficient for that, of course, but not necessary. Any idea how it looks from that perspective?